Guangzhou MingCeler Biotech Co., Ltd

09/06/2026

From Cell Stem Cell to the ASGCT Stage: MingCeler Powers Next-Gen Reprogramming

A huge congratulations to our partner, Sergey Velyichko (Soxigen), for an incredible invited talk at ASGCT showcasing their revolutionary Super-SOX reprogramming technology!

MingCeler is proud to be part of this landmark study (originally published in Cell Stem Cell), with our own Dr. Guangming Wu featured as a co-author. Utilizing our proprietary TurboMice™ Tetraploid Complementation platform, we provided the critical embryo manipulations and generated the all-iPSC mouse models for the project. These animals served as the ultimate functional proof that Super-SOX stabilizes the Sox2/Oct4 heterodimer and enhances pluripotency across mice, humans, primates, and large animals.

While conventional tetraploid technology struggles with a low 1%–5% birth rate worldwide, MingCeler's optimized platform delivers significantly higher efficiency, transforming a notoriously difficult technique into a reliable tool for high-impact research.

It is an honor to see research powered by MingCeler featured on the global cell and gene therapy stage. We look forward to empowering more scientific breakthroughs in the future!

19/05/2026

🐭 Struggling with slow mouse model turnaround? Tired of genetic drift messing with results? We get it—delays and inconsistencies derail research.

That’s why we built our platform:
✅ Skip 6+ months of breeding—get homozygous F0 mice in 2 months with TurboMice™ tech.
✅ No more genetic drift: Our cryopreserved ES cells lock in integrity, so your data stays reliable.
✅ Tackle big edits (200kb+ knock-ins, Mb deletions) like it’s routine—no more hitting technical walls.

Spend less time waiting, more time discovering.

15/05/2026

Last day at ! We're proud to share our custom mouse models for disease research. Grateful for all the inspiring conversations and connections. We are looking forward to future collaborations!

14/05/2026

Our team at on Day 3! Inspiring insights, great science, and an incredible community driving innovation forward.
Welcome to booth #1456 and take a look!

14/05/2026

Sharing our expertise in custom HD mouse models tailored to Huntington's disease research.
On Day 3 of , we're here in Boston showcasing how our reliable preclinical animal models support gene therapy development.

MingCeler's TurboMice custom HD mouse models tailored for Huntington's disease preclinical research.

13/05/2026

Our team and little mascot are out here connecting with the gene therapy community and sharing how we’re speeding up preclinical research with TurboMice™. Day 2 at Boston!
Come say hi if you’re around! 👋

13/05/2026

Day 2 at Boston!Great discussions with global researchers & partners about gene therapy & rare disease models.
Today we highlight our HGPS progeria mouse models—including in-stock Lamin A mice & custom solutions powered by TurboMice™ to accelerate your preclinical R&D.
Visit our booth to learn how we deliver homozygous models in 2 months. Looking forward to more collaborations!

MingCeler offers in-stock Lamin A progeria mice and custom HGPS models for aging research and drug development.

12/05/2026

🔬 Advancing Metabolic Disease Research with MingCeler’s Precision Model Mice​
Are you studying obesity, diabetes, fatty liver, atherosclerosis, or gout? Do you need reliable, humanized, and precisely edited metabolic models​ to validate drug targets or uncover disease mechanisms?

At MingCeler, we specialize in custom gene-edited metabolic model mice—including whole-body/tissue-specific knockout, knock-in, point mutation, and humanized models—to accurately mimic human metabolic diseases.

✨ Why Choose MingCeler’s Models?
Broad Disease Coverage: Simulate obesity, diabetes, fatty liver, atherosclerosis, hyperuricemia (gout), cardiovascular diseases, and more.
Precision Gene Editing: From Msr1 point mutations (macrophage function/atherosclerosis) to humanized GCGR (type 2 diabetes) or Uox knockout (gout), our models replicate human genetic variants or deficiencies.
Translational Relevance: Perfect for mechanism research, drug target validation, and novel therapy development.

📩 Ready to Elevate Your Research?
Whether you’re exploring disease mechanisms or developing next-gen therapies, our metabolic model mice empower your work.

👉 Learn more about our models https://www.mingceler.com/

11/05/2026

Transthyretin amyloidosis (ATTR) research relies on reliable preclinical models.
MingCeler provides custom ATTR mouse models including, but not limited to:
• ATTR V30M mice
• hTTR A97S mice
• TTR/RBP4 double humanized mice
Powered by TurboMice™, we deliver homozygous models in 2 months.
Welcome to share your project needs.

Transthyretin amyloidosis (ATTR) research relies on reliable preclinical models. MingCeler provides custom ATTR mouse models including, but not limited to:• ATTR V30M mice• hTTR A97S mice• TTR/RBP4 double humanized mice Powered by TurboMice™, we deliver homozygous models in 2 months.Welcome ...